Published 2 days ago • loading... • Updated 8 hours ago
Remedy Robotics Raises $62 Million Series B to Bring Life-Saving Cardiovascular Intervention to Patients Everywhere
Summary by PR Newswire
6 Articles
6 Articles
Remedy Robotics Raises $62 Million Series B to Bring Life-Saving Cardiovascular Intervention to Patients Everywhere
/PRNewswire/ -- Remedy Robotics, Inc. ("Remedy"), a leading healthcare and physical AI company developing robotic systems for cardiovascular care and...
Remedy Robotics Raises $62M to Advance Remote Endovascular Stroke Robotics Toward FDA Approval
What You Should Know The N1 Platform: Physical AI, Preoperative Simulation, and Remote Endovascular Execution Backed by 48 issued patents spanning machine learning and surgical robotics, Remedy Robotics engineered the N1 System to decouple specialist expertise from physical bedside presence. The platform integrates precision catheter-driving hardware with an artificial intelligence software suite capable of supporting ...
Coverage Details
Total News Sources6
Leaning Left0Leaning Right0Center1Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium








